Net proceeds from the financing will now provide “additional financial flexibility” as the firm continues clinical development efforts.
The post Filament Health to raise nearly C$1M, plans Cboe Canada delisting appeared first on Green Market Report.
Your email address will not be published. Required fields are marked *